Jennison Associates’s Editas Medicine EDIT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-237,745	Closed	-$811K	–	600
2024 Q3	$811K	Buy	237,745 +112,857	+90%	+$491K	﹤0.01%	505
2024 Q2	$583K	Buy	124,888 +18,368	+17%	+$104K	﹤0.01%	540
2024 Q1	$790K	Buy	106,520 +24,000	+29%	+$199K	﹤0.01%	517
2023 Q4	$836K	Sell	82,520 -10,280	-11%	-$90.2K	﹤0.01%	510
2023 Q3	$724K	Sell	92,800 -24,981	-21%	-$214K	﹤0.01%	504
2023 Q2	$969K	Buy	117,781 +21,927	+23%	+$191K	﹤0.01%	486
2023 Q1	$695K	Buy	95,854 +2,977	+3%	+$26.5K	﹤0.01%	536
2022 Q4	$824K	Buy	92,877 +36,483	+65%	+$400K	﹤0.01%	517
2022 Q3	$690K	Sell	56,394 -7,380	-12%	-$115K	﹤0.01%	551
2022 Q2	$754K	Buy	63,774 +11,061	+21%	+$148K	﹤0.01%	549
2022 Q1	$1M	Buy	+52,713	New	+$980K	﹤0.01%	558
2016 Q3	–	Sell	-170,940	Closed	-$4.13M	–	662
2016 Q2	$4.13M	Hold	170,940	–	–	﹤0.01%	506
2016 Q1	$5.7M	Buy	+170,940	New	+$4.49M	0.01%	486